This webinar offers a platform for attendees to engage with a diverse group of Medical Affairs omnichannel experts, discover their distinctive perspectives, navigate common obstacles, and gain firsthand insights into pragmatic omnichannel integration solutions.
The MAPS Puerto Rico Roundtable hosted by Real Chemistry in March 2024 discussed the integration of digital platforms, AI, and personalized content to enhance engagement with healthcare providers (HCPs). The panel emphasized the shift towards real-time, tailored information delivery and the importance of leveraging insights from both traditional and digital sources to support effective engagement strategies while ensuring compliance.
MAPS has been educating and sharing expertise on genAI since ChatGPT first exploded onto the scene in early 2023. This year, as the dust settles, we focus on sharing the learnings from a year of pilots and projects to help others begin or accelerate their journey.
In this podcast, we explore machine learning as a way to get information about an audience.
In this podcast, we dive into a really important area that can significantly influence your GenAI results – Prompt Engineering and other areas.
This webinar will give attendees a better understanding of use-cases of Generative AI in Medical Affairs and will show results to help inform thinking and build a future roadmap.
10 reasons digital strategies fail plus ways you and your teams can navigate between the icebergs of these failures on the way to success.
This article discusses how to foster innovation within and across the Medical Affairs landscape, empower teams to deliver the best outcomes for patients and revolutionize healthcare delivery.
MAPS speaks with Amit Lalwani, omnichannel lead and member of the Core Planning Team for the MAPA/MAPS Medical Affairs Summit, Nov 8-10, 2023 in Sydney, AU.
In this on-demand webinar, experts discuss how to understand the difference between the theoretical potential of generative AI and real applications Medical Affairs can leverage now.